The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the ...

A blood test that screens for more than 50 cancers is correct in 62% of cases where it thinks people may have the disease, a ...

Among those groups is one led by James Voss, an immunologist at Scripps Research in La Jolla, California, who plans to use the mice to advance his work ... “It makes no sense to test them in animal ...

The blood-based test detects phosphorylated tau 181, a biomarker that is correlated with the presence of amyloid pathology in ...

The Peninsula company's investors include Stanford and Chan Zuckerberg Biohub.

In this innovation-focused webinar, we’ll explore how syndromic testing is transforming the diagnostic and clinical management of bloodstream infections (BSIs). Featuring real-world ex ...

Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key ...

A new uptick in mpox activity, including reports of more virulent clade I lineages circulating in multiple regions, has renewed questions from employers about their obligations when an employee is ...